Robust predictor of breast cancer risk
Ended Project Grant Awarded Last action
- Award ID
- R42CA217383
- Recipient
-
Morgan And Mendel Genomics, Inc. UEI JHNHD3R1TCT8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,335,239
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Funding
-
- $3,327,035.89 Federal
- $1,008,203.00 Non-federal
- Place of performance
- Bronx, NY 10461, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$1,167 | $0 | |
| Amendment | $160,000 | $0 | |
| Amendment | $160,000 | $0 | |
| Amendment | $1,008,203 | $0 | |
| Amendment | $1,008,203 | $1,008,203 | |
| Original award | $991,797 | $0 |
Quick answers
Who received award R42CA217383?
R42CA217383 was awarded to Morgan And Mendel Genomics, Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2017.
How much is award R42CA217383 worth?
$4,335,239 has been obligated on R42CA217383: $3,327,036 in federal funding and $1,008,203 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award